Common Contracts
6 similar Exclusive License Agreement contracts by Ocean Biomedical, Inc.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 27th, 2022 • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of January 25, 2021 , 2021 (the “Effective Date”), by and between Elkurt Inc. a Rhode Island corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT BROWN ID 3039 - Bi Specific Antibody Anti-CTLA4Exclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”), by and between Elkurt Inc. a Delaware corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT RIH #154 “PfsLSP-1 a Vaccine for Falciparum Malaria” RIH # 305 “Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and Protect Against Infection and Severe Disease”Exclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of January 25, 2021 , 2021 (the “Effective Date”), by and between Elkurt Inc. a Rhode Island corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT BROWN ID 2465, 2576, 2587 (FRG) AntibodyExclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”), by and between Elkurt Inc. a Delaware corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT BROWN ID 2613 Bispecific (FRG)xAnti-PD-1 (FRGxPD-1)Exclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”), by and between Elkurt Inc. a Delaware corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
EXCLUSIVE LICENSE AGREEMENT BROWN ID 2502 - (Chit1) Small Molecule AntifibroticExclusive License Agreement • June 22nd, 2021 • Ocean Biomedical, Inc. • Pharmaceutical preparations • Rhode Island
This Exclusive License Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”), by and between Elkurt Inc. a Delaware corporation, with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc, a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
